Skip to content
pwrlogoonlyoutlinejpglow

Call us at (520) 591-5346

Give Today!

A 501(c)3 Organization

  • Home
  • About PWR!
    • Our Mission
    • Our Team
    • Board of Directors
    • Careers
    • PWR! Updates & News
    • Contact Us
  • For People with Parkinson’s
    • PWR!Gym
      • PWR!Gym Calendar
    • Therapy Intensive
    • Live Class Links Login
    • PWR! Virtual Experience
    • PWR! Retreat
    • Outside of Southern Arizona
    • Find a PWR!Moves Professional in Your Area
  • For Professionals
    • About Our Workshops
    • Workshops for Therapists
    • Therapist Recertifications
    • Workshops for Exercise Instructors
    • Instructor Recertification
    • Education Faculty
    • Add / Update Your Directory Listing
  • Resources
    • About the PWR!Moves
    • Watch the PWR!Moves
    • Parkinson Research
    • Wellness Series
    • Recommended Equipment
    • PWR!Gym Calendar
  • Search

Lorente-PicnM, Laguna A. New Avenues for Parkinsons Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.Biomolecules. 2021;11(3):433. doi:10.3390/biom11030433

January 17, 2022
Read More

Perlmutter J,UsheM. Parkinson’s Disease – What’s the FUS? NEnglJ Med. 2020 Dec 24;383(26):2582-2584.doi: 10.1056/NEJMe2031151.

January 17, 2022
Read More

Rowe JB, et al. Parkinsons disease and dopaminergic therapy–differential effects on movement, reward and cognition.Brain2008; 131:2094-2105.

January 17, 2022
Read More

ThanviBR. Long term motor complications of levodopa: clinical features, mechanisms, and management strategies. Postgrad Med J. 2004;80(946):452-458. doi:10.1136/pgmj.2003.013912

January 17, 2022
Read More

Williams NR, Foote KD, Okun MS. Subthalamic Nucleus Versus Globus Pallidus Internus Deep Brain Stimulation: Translating the Rematch Into Clinical Practice.MovDisordClinPract. 2014;1(1):24-35. doi:10.1002/mdc3.12004

January 17, 2022
Read More

ElkouziA,Vedam-Mai V,EisingerRS, Okun MS. Emerging therapies in Parkinson disease repurposed drugs and new approaches.Nat Rev Neurol. 2019;15(4):204-223. doi:10.1038/s41582-019-0155-7

January 17, 2022
Read More

FerrazzoliD,OrtelliP,RiboldazziG,MaestriR,FrazzittaG. Effectiveness ofRotigotineplus intensive and goal-based rehabilitation versusRotigotinealone in de-novo Parkinsonian subjects: a randomized controlled trial with 18-month follow-up.J Neurol. 2018;265(4):906-916. doi:10.1007/s00415-018-8792-0

January 17, 2022
Read More

FerrazzoliD, Carter A,UstunFS, et al. Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinsons Disease: Implications for Rehabilitation. FrontBehavNeurosci. 2016;10. doi:10.3389/fnbeh.2016.00121

January 17, 2022
Read More

Willis AW,EvanoffBA, Lian M, Criswell SR, Racette BA.Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries.Neuroepidemiology2010;34:143151, DOI: 10.1159/000275491

January 17, 2022
Read More

MarrasC, Beck JC, Bower JH, et al. Prevalence of Parkinsons disease across North America.npjPark Dis. 2018;4(1):21. doi:10.1038/s41531-018-0058-0

January 17, 2022
Read More
« Newer Posts
Older Posts »
  • About PWR!
  • Contact Us
  • Donation
  • Conduct Policy
  • About PWR!Moves
  • Watch the PWR!Moves
  • Parkinson’s Research
  • PWR!Gym
  • PWR! Workshops
  • PWR! Retreat
  • PWR! Virtual Experience
© 2025 Parkinson Wellness Recovery | PWR! | Powered by Visual Design Services
Scroll To Top
We use cookies to ensure that we give you the best experience on our website. Continued use of the site means you are in understanding of our policies.